Page 150 - Vitamin D and Cancer

6 Vitamin D: Cardiovascular Function and Disease 137

98. Lind L, Wengle B, Ljunghall S (1987) Blood pressure is lowered by vitamin D (alphacalci-
dol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind,
placebo-controlled study. Acta Med Scand 222:423–427
99. Lind L, Lithell H, Skarfors E, Wide L, Ljunghall S (1988) Reduction of blood pressure by
treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with
impaired glucose tolerance. Acta Med Scand 223:211–217
100. Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S (1989) Long-term
treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose
tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure.
Diabetes Res 11:141–147
101. Orwoll ES, Oviatt S (1990) Relationship of mineral metabolism and long-term calcium and
cholecalciferol supplementation to blood pressure in normotensive men. Am J Clin Nutr
52:717–721
102. Orwoll ES, Weigel RM, Oviatt SK, McClung MR, Deftos LJ (1988) Calcium and cholecal-
ciferol: effects of small supplements in normal men. Am J Clin Nutr 48:127–130
103. Gillor A, Groneck P, Kaiser J, Schmitz-Stolbrink A (1989) Congestive heart failure in rickets
caused by vitamin D deficiency. Monatsschr Kinderheilkd 137:108–110
104. Connor TB, Rosen BL, Blaustein MP, Applefeld MM, Doyle LA (1982) Hypocalcemia
precipitating congestive heart failure. N Engl J Med 307:869–872
105. Brunvand L, Haga P, Tangsrud SE, Haug E (1995) Congestive heart failure caused by
vitamin D deficiency? Acta Paediatr 84:106–108
106. Uysal S, Kalayci AG, Baysal K (1999) Cardiac functions in children with vitamin D
deficiency rickets. Pediatr Cardiol 20:283–286
107. McGonigle RJ, Timmis AD, Keenan J, Jewitt DE, Weston MJ, Parsons V (1981) The
influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal
failure. Proc Eur Dial Transplant Assoc 18:579–585
108. Coratelli P, Petrarulo F, Buongiorno E, Giannattasio M, Antonelli G, Amerio A (1984)
Improvement in left ventricular function during treatment of hemodialysis patients with
25-OHD3. Contrib Nephrol 41:433–437
109. Lemmila S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A (1998) Effect of intravenous
calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am
J Nephrol 18:404–410
110. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK
(1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with
secondary hyperparathyroidism. Am J Kidney Dis 33:73–81
111. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ
(1997) Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart
failure. Am J Med 103:197–207
112. Kunitomo M, Kinoshita K, Bando Y (1981) Experimental atherosclerosis in rats fed a
vitamin D, cholesterol-rich diet. J Pharmacobiodyn 4:718–723
113. Takeo S, Schraven E, Keil M, Nitz RE (1982) Vitamin D-induced myocardial lesions and the
protection by carbocromen. Arzneimittelforschung 32:1412–1417
114. Toda T, Leszczynski DE, Kummerow FA (1983) The role of 25-hydroxy-vitamin D3 in the
induction of atherosclerosis in swine and rabbit by hypervitaminosis D. Acta Pathol Jpn
33:37–44
115. Atkinson J (1992) Vascular calcium overload. Physiological and pharmacological
consequences. Drugs 44(Suppl 1):111–118
116. Fleckenstein-Grun G, Thimm F, Frey M, Matyas S (1995) Progression and regression by
verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
J Cardiovasc Pharmacol 26:207–213
117. Bennani-Kabchi N, Kehel L, el Bouayadi F, Fdhil H, Amarti A, Saidi A, Marquie G (1999)
New model of atherosclerosis in sand rats subjected to a high cholesterol diet and vitamin
D2. Therapie 54:559–565